Literature DB >> 21985304

Aspergillosis in the 'nonimmunocompromised' host.

David A Stevens1, George L Melikian.   

Abstract

Invasive aspergillosis has been classically associated with certain risk factors: cytotoxic chemotherapy, prolonged neutropenia, corticosteroids, transplantation, AIDS. However, the literature is growing that this mycosis, particularly pulmonary aspergillosis, can be seen in patients lacking these factors. Many of the latter patients are in the intensive care unit. Other associated conditions include influenza, nonfungal pneumonia, chronic obstructive lung disease, immaturity, sepsis, liver failure, alcoholism, chronic granulomatous disease and surgery. Certain focal sites, such as sinusitis or cerebral aspergillosis, have additional risk factors. This emphasizes the potential importance of a positive culture for Aspergillus in the critically ill, the need for awareness about possible aspergillosis in patients lacking the classical risk factors, and readiness to proceed with appropriate diagnostic maneuvers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985304     DOI: 10.3109/08820139.2011.614307

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  28 in total

1.  Clinical in vestigation of misdiagnosis of invasive pulmonary aspergillosis in 26 immunocompetent patients.

Authors:  Rong-Rong Zhang; Su-Fang Wang; Huai-Wei Lu; Zhi-Hua Wang; Xiao-Ling Xu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  Misdiagnosis of invasive pulmonary aspergillosis: a clinical analysis of 26 immunocompetent patients.

Authors:  Rongrong Zhang; Sufang Wang; Huaiwei Lu; Zhihua Wang; Xiaoling Xu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 4.  Resolution of Isolated, Aspergillus Colonization in a Deep Esophageal Ulcer in an Immunocompetent Patient with Ulcer Healing Without Specific Antifungal Therapy.

Authors:  Mitchell S Cappell; Dupinder Singh; Ross Sage; Mitual B Amin
Journal:  Dig Dis Sci       Date:  2016-03-16       Impact factor: 3.199

5.  Aspergillus infections in transplant and non-transplant surgical patients.

Authors:  Stephen Davies; Christopher Guidry; Amani Politano; Laura Rosenberger; Matthew McLeod; Tjasa Hranjec; Robert Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2014-05-05       Impact factor: 2.150

6.  RNA-Seq Profile Reveals Th-1 and Th-17-Type of Immune Responses in Mice Infected Systemically with Aspergillus fumigatus.

Authors:  Jata Shankar; Gustavo C Cerqueira; Jennifer R Wortman; Karl V Clemons; David A Stevens
Journal:  Mycopathologia       Date:  2018-03-02       Impact factor: 2.574

7.  Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation.

Authors:  Steven G E Braem; Suzan H M Rooijakkers; Kok P M van Kessel; Hans de Cock; Han A B Wösten; Jos A G van Strijp; Pieter-Jan A Haas
Journal:  J Innate Immun       Date:  2015-02-10       Impact factor: 7.349

Review 8.  Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature.

Authors:  Melisa M Shah; Eric I Hsiao; Carl M Kirsch; Amit Gohil; Supriya Narasimhan; David A Stevens
Journal:  Diagn Microbiol Infect Dis       Date:  2018-02-02       Impact factor: 2.803

Review 9.  Characteristic clinical features of Aspergillus appendicitis: Case report and literature review.

Authors:  Mihajlo Gjeorgjievski; Mitual B Amin; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

10.  Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation.

Authors:  J Held; T Schmidt; C R Thornton; E Kotter; H Bertz
Journal:  Infection       Date:  2013-05-10       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.